Post by European Vaccine Initiative (EVI)

Today, European Vaccine Initiative (EVI) joins forces with seven Product Development Partnerships (PDPs) to call for sustained investment in the European & Developing Countries Clinical Trials Partnership (EDCTP) under the next EU Framework Programme for Research and Innovation (FP10) and other EU funding frameworks under discussion. For more than 20 years, EDCTP has demonstrated the impact of Europe–Africa collaboration, supporting clinical research, strengthening scientific capacity and accelerating the development of health innovations that address poverty-related and neglected diseases. Beyond its role as a research funding instrument, EDCTP serves as a strategic platform connecting Europe’s global health, research and innovation agendas. As global health challenges evolve, continued investment in EDCTP will be essential to ensure Europe and Africa remain at the forefront of discovery, innovation and preparedness for emerging threats. Read more about the impact of the collaboration between PDPs and EDCTP, and our recommendations➡️ https://lnkd.in/eXtJ7XBp #EUResearchFunding #FP10 #EDCTP #GlobalHealth #ResearchAndInnovation Global Health EDCTP3 | European Commission | Drugs for Neglected Diseases initiative (DNDi) | FIND | Global Antibiotic R&D Partnership (GARDP) | IAVI | Medicines Development for Global Health | Medicines for Malaria Venture | TB Alliance